Dexmedetomidine and Adenosine: Therapeutic Use for SVT

• Status: Completed
• Trial end date: 2014-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the efficacy and safety of dexmedetomidine in the acute termination of Supraventricular Tachycardia (SVT).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Pittsburgh
• Treatments: Adenosine; Dexmedetomidine

Criteria

Inclusion Criteria:

• Patients between the age of 5 - 30 years old, who are scheduled for cardiac electrophysiology study for evaluation of reentrant SVT

Exclusion Criteria:

• Severe Heart Failure

• Presence of of any other antiarrhythmic medication within 24 hours of enrollment

• Third degree heart block

• Sick Sinus Syndrome